Carisma Therapeutics (CARM) Stock Price
Carisma Therapeutics Price
Revenue has compounded at 27.7% per year over the past 11 years to 19.63 M USD. Carisma Therapeutics's net margin stands at -308.1%, down from -200.5% several years earlier. Carisma Therapeutics currently offers a dividend yield of about 0.18%.
Carisma Therapeutics stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Carisma Therapeutics business model & stock analysis
Frequently asked questions about Carisma Therapeutics
6 analysts currently rate the Carisma Therapeutics stock: 0 recommend buying, 3 holding and 3 selling.
Converted at the current exchange rate, the Carisma Therapeutics share trades at 0.00 EUR (0.00 USD).
The Carisma Therapeutics share (CARM) is listed on 3 stock exchanges, including: NASDAQ (CARM), Frankfurt (W2J.F), München (W2J.MU).
The revenue cannot currently be calculated for Carisma Therapeutics.
The expected profit of Carisma Therapeutics is -22.20 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Carisma Therapeutics is currently -0.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Carisma Therapeutics stock.
The P/S cannot be calculated for Carisma Therapeutics currently.
The Eulerpool Quality Score for Carisma Therapeutics is 4/10.
The ISIN of Carisma Therapeutics is US14216R1014. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Carisma Therapeutics is A3DZG2. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Carisma Therapeutics is CARM. The ticker symbol is used to trade Carisma Therapeutics shares on the stock exchange.
Carisma Therapeutics stock
Carisma Therapeutics Peer Group
Carisma Therapeutics Ticker
Carisma Therapeutics FIGI
All fundamentals and in-depth analysis of Carisma Therapeutics
Our stock analysis for Carisma Therapeutics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Carisma Therapeutics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.